The farnesoid X receptor (FXR) is a bile acid nuclear receptor that plays a crucial role in regulating bile acid and sterol metabolism.

WALKING into the WeightWatchers meeting with her mum, then-eight-year-old Sarah Le Brocq was wide-eyed. It was 1990 and she ...

Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

Transformational drugs rarely emerge from a targeted, application-driven approach. Rather, they arise from deep scientific inquiry over many years, an approach that only robust, early-stage funding ...

LOS ANGELES, CA, USA I March 03, 2025 I Laekna (2105.HK) announced that the U.S. Food and Drug Administration (FDA) has approved the IND for LAE120, an ...

The news has been littered with stories these days about people losing weight using GLP-1 weight loss drugs like Ozempic. Now ...

Here's why I think it can be the best GLP-1 stock to buy this year. Amgen's weight loss drug only needs to be taken once a month The top GLP-1 treatments on the market today require weekly injections.

Feb 27, 2025 Nikhil Kaitwade Comment on Global GLP-1 Receptor Agonist Market Set for Remarkable Growth, Projected to Reach USD 72,127.79 Million by 2034 grow at a CAGR of 11.7% The global GLP-1 ...

ABSTRACT: Obesity has become a global chronic metabolic disease, posing a serious threat to public health. Glucagon-like peptide-1 (GLP-1) is an important hormone secreted by the L cells of the small ...

Identifying and delineating cell structures in microscopy images is crucial for understanding the complex processes of life. This task is called "segmentation" and it enables a range of ...

Now, he's back in Australia with his live show 'Unfiltered'. He chats with News Breakfast about why Formula 1's recent swearing ban is unrealistic.